Related Experiment Video

Updated: Jun 10, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

PLCD1 is a functional tumor suppressor inducing G(2)/M arrest and frequently methylated in breast cancer

Tingxiu Xiang1, Lili Li, Yichao Fan

  • 1Molecular Oncology and Epigenetics Laboratory, The First Affiliated Hospital, Chongqing Medical University, Chongqing, China.

Cancer Biology & Therapy
|July 27, 2010
PubMed

Insights

Phospholipase C delta 1 (PLCD1) is frequently silenced by promoter methylation in breast cancer, acting as a tumor suppressor. This epigenetic silencing inhibits tumor growth, migration, and promotes cell cycle arrest, suggesting PLCD1 as a potential biomarker.

Area of Science:

  • Cancer epigenetics
  • Molecular oncology
  • Tumor suppressor genes

Background:

  • Chromosome 3p contains critical tumor suppressor genes involved in cancer development.
  • PLCD1 (Phospholipase C delta 1), located at 3p22, plays roles in cellular signaling pathways.
  • Epigenetic alterations, particularly promoter methylation, are key mechanisms for gene silencing in cancer.

Purpose of the Study:

  • To investigate the epigenetic alterations of PLCD1 in breast cancer.
  • To determine the tumor suppressor function of PLCD1 in breast cancer.
  • To evaluate PLCD1 methylation as a potential biomarker for breast cancer.

Main Methods:

  • Semi-quantitative PCR to assess PLCD1 expression levels.
  • Methylation-specific PCR (MSP) and Bisulfite Genomic Sequencing (BGS) to detect promoter methylation.
  • Pharmacological demethylation and ectopic PLCD1 expression in cancer cell lines.

Main Results:

  • Frequent downregulation and silencing of PLCD1 observed in breast cancer cell lines.
  • High frequency of PLCD1 promoter methylation in breast cancer cell lines (78%) and primary tumors (52%), absent in normal tissues.
  • Pharmacological demethylation reversed PLCD1 silencing; ectopic PLCD1 expression inhibited colony formation, migration, and induced G2/M cell cycle arrest.

Conclusions:

  • PLCD1 is frequently inactivated by promoter methylation in breast cancer, confirming its role as a tumor suppressor.
  • PLCD1's tumor-inhibitory functions include suppressing proliferation, migration, and inducing cell cycle arrest.
  • Tumor-specific methylation of PLCD1 presents a potential biomarker for early detection and prognosis of breast cancer.

More Related Videos

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.